LOGIN
Perioperative aspirin reduces major cardiac adverse events following non-cardiac surgery
October 2014
Perioperative aspirin reduces major cardiac adverse events following non-cardiac surgery
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial
Br J Anaesth. 2010 Mar;104(3):305-12. doi: 10.1093/bja/aeq003.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
220 high-risk patients undergoing elective, high- or intermediate-risk non-cardiac surgery were randomized to receive either aspirin (75 mg) or placebo daily, beginning 7 days prior to surgery until the third postoperative day. The purpose of this study was to determine whether continuing aspirin therapy in the perioperative period significantly reduced myocardial damage and the incidence of major...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.